ARCHIVES

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

This article is from The Cancer Letter archive.

Vol. 31 No. 34 | September 23, 2005

Download PDF Visit The Full Archive

Related Articles

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

Health Association Oppose U.S. Trade Policy On Tobacco Exports; Recommend Restrictions

August 25, 1989

CTEP Drafts FDA Approval Guidelines

March 4, 1988

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006